Objective: To evaluate the cost-effectiveness and treatment-cost impact of sinecatechins
(Veregen) as first-line therapy against its principal comparator, imiquimod (Aldara), in the …

Objective External genital warts are one of the fastest growing sexually transmitted diseases
in the United States today. Two forms of therapy are available: provider-administered and …

With the availability of new patient-applied treatments for genital and perianal warts, medical
providers, physician groups, and health systems are reassessing the role of physician …

A model was developed to estimate the cost-effectiveness of podophyllotoxin and imiquimod
for self-treatment of anogenital warts. The effectiveness endpoint was sustained clearance …

The objective of the study was to determine the cost implications of patterns of treatment for
patients with external genital warts. A retrospective case note review was carried out at six …

External genital warts (EGW) are a sexually transmitted infection caused by various strains
of human papillomavirus (HPV). Several studies have described the direct and indirect costs …

BACKGROUND Typically occurring on the external genitalia, anogenital warts (AGWs) are
benign epithelial skin lesions caused by human papillomavirus infection. AGWs are usually …

Background. Genital warts is a common sexually transmitted disease treated by a variety of
medical specialists. Standard therapies offer symptomatic relief but cannot ensure lasting …

Genital warts are one of the most commonly reported sexually transmitted diseases
worldwide. A variety of treatment options are available but few have been assessed in large …

Background: Postmarketing research has explored the optimal application schedule of
imiquimod 5% cream for treatment of external anogenital warts. Objectives: We systemically …